Effects of Anorexia Nervosa on Peak Bone Mass

$761,549R01FY2005DKNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

Paper 35807738 Paper 33693703 Paper 33418100 Paper 32252004 Paper 31648221 Paper 30853658 Paper 30165608 Paper 29659886 Paper 28980367 Paper 28694162 Paper 28593722 Paper 28152193 Paper 27387309 Paper 26863308 Paper 26311400 Paper 24898127 Paper 24790401 Paper 24731664 Paper 24576482 Paper 24430890 Paper 24275621 Paper 24079076 Paper 24021517 Paper 23653430 Paper 23509107 Paper 23331192 Paper 23218167 Paper 22733643 Paper 22728230 Paper 21897220 Paper 21698665 Paper 21301203 Paper 21228564 Paper 20375207 Paper 19926712 Paper 19523548 Paper 19344792 Paper 19248866 Paper 19064506 Paper 19011190 Paper 18544623 Paper 18519482 Paper 18519455 Paper 18331605 Paper 18089702 Paper 18089697 Paper 17878248 Paper 17356044 Paper 17137889 Paper 17023694 Paper 16972186 Paper 16549537 Paper 16278259 Paper 15811876 Paper 15755766 Paper 15713709 Paper 15641865 Paper 15574617 Paper 15472193 Paper 15240636 Paper 15070919

Abstract

DESCRIPTION (provided by applicant): Anorexia nervosa is an increasingly common disorder in adolescent girls with a prevalence of 0.2 to 1.0% in Western societies. Adolescence is a critical time for bone mineral accretion as between 60-90% of peak bone mass is established during this time and peak bone mass is a major determinant of osteoporosis and fracture risk throughout life. Osteopenia is a complication of anorexia nervosa in more than half of affected women and is associated with clinical fractures. Little is known about the pathogenesis of osteopenia in adolescents and there are no established therapies to maximize peak bone mass and prevent fractures. Although anorexia nervosa is associated with profound estrogen deficiency and estrogen is known to be a critical factor in bone development, the effects of estrogen administration have not been investigated in adolescents with this disorder. In the current proposal, disordered bone metabolism and body composition will be investigated and the effects of anorexia nervosa on growth hormone and nutritionally dependent endpoints will be examined. In the first Specific Aim we will prospectively investigate the disordered state of bone mineral accretion in pubertal adolescents with anorexia nervosa. Predictive factors leading to low bone density will be studied as well as the effect of anorexia nervosa on linear growth, predicted height and growth hormone secretion. In the second Aim we will investigate the hypothesis that estrogen administration given to adolescents with anorexia nervosa, in a bone-age, dose-dependent manner will increase bone density during the development of peak bone mass, stimulate IGF-I levels and stimulate linear growth in girls with immature bone age. These studies will be essential in developing strategies to address the profound loss of bone accrual seen in this large population of adolescent girls at high fracture risk.

View original record on NIH RePORTER →